This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Eosinophilia
D3_EOSINOPHILIA
Hypereosinophilic syndrome: The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
595 |
4. Check minimum number of eventsNone |
595 |
5. Include endpointsNone |
595 |
6. Filter based on genotype QC (FinnGen only) |
571 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D72
- Name in latin
- Eosinophilia
Similar endpoints
↥List of similar endpoints to
Eosinophilia
based on the number of shared cases.
Similar with more cases:
- Eosinophilic disease (BM)
- Other disorders of white blood cells
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Excluding asthma or asthma-COPD overlap
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 571 | 305 | 266 |
| Unadjusted period prevalence (%) | 0.11 | 0.11 | 0.12 |
| Median age at first event (years) | 57.03 | 53.06 | 61.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 595
- Matched controls
- 5950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D72.1
ICD-10 Finland
Eosinophilia
+∞
307.7
579
*
XW000
NOMESCO Finland
Bone marrow biopsy
13.2
104.3
107
97
J32.4
ICD-10 Finland
Chronic pansinusitis
26.8
98.1
69
29
J45.1
ICD-10 Finland
Nonallergic asthma
7.9
87.2
137
216
J45.9
ICD-10 Finland
Asthma, unspecified
5.3
82.6
238
667
R03AK08
ATC
formoterol and beclometasone; inhalant
11.1
78.3
89
93
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.7
78.0
99
120
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
33.2
70.8
46
15
H02AB06
ATC
prednisolone; systemic
4.8
70.3
426
2045
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.6
69.1
231
715
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
13.7
66.0
64
52
J33.0
ICD-10 Finland
Polyp of nasal cavity
11.9
64.8
69
65
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.0
64.6
134
276
R03DC03
ATC
montelukast; oral
4.7
64.0
197
568
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
11.2
57.3
63
62
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.5
54.5
99
178
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
7.0
52.2
87
143
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
5.7
51.4
109
227
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
50.0
383
1984
R03BB04
ATC
tiotropium bromide; inhalant
5.0
49.9
126
305
XG474
NOMESCO Finland
Exhalation nntrogen oxide
8.9
47.0
61
75
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
42.5
280
1289
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
231.3
42.5
43
*
J45
ICD-10 Finland
Asthma
4.6
41.5
114
293
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.1
41.1
96
216
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
6.4
40.7
72
125
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
214.0
39.3
40
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.1
37.3
59
91
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
37.3
137
434
R03BA08
ATC
ciclesonide; inhalant
4.5
35.9
99
254
J46
ICD-10 Finland
Status asthmaticus
8.9
35.2
45
54
J45.8
ICD-10 Finland
Mixed asthma
8.1
34.0
47
62
DHB20
NOMESCO Finland
Polypectomy of internal nose
11.2
33.4
36
34
XQ800
NOMESCO Finland
Prick test
4.6
32.6
85
208
R01AD08
ATC
fluticasone; nasal
2.9
32.5
234
1098
J33.8
ICD-10 Finland
Other polyp of sinus
8.6
32.0
42
52
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
31.8
105
307
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
31.6
89
231
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.3
31.6
143
514
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.1
31.5
49
74
R03AC02
ATC
salbutamol; inhalant
2.7
29.4
399
2533
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.2
29.3
52
90
R03BA05
ATC
fluticasone; inhalant
3.0
29.0
162
656
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
28.9
100
301
H02AB07
ATC
prednisone; oral
3.3
28.6
127
449
WZC30
NOMESCO Finland
Teaching
3.1
28.3
144
552
H02AB09
ATC
hydrocortisone; systemic
7.6
27.4
40
56
R50.9
ICD-10 Finland
Fever, unspecified
3.1
27.1
137
522
H02AB04
ATC
methylprednisolone; systemic
3.1
26.8
133
502
ZX112
NOMESCO Finland
Subcutaneous
7.4
26.2
39
56
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
25.0
199
961
TGC00
NOMESCO Finland
Bronchial lavation
6.1
24.0
43
75
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
23.6
218
1123
ZXE00
NOMESCO Finland
One hour or less
2.4
23.5
280
1616
R03AK11
ATC
formoterol and fluticasone; inhalant
6.7
23.4
38
60
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.6
23.3
46
88
R96
ICPC
Asthma
3.5
23.2
89
285
R03AK07
ATC
formoterol and budesonide; inhalant
2.6
22.5
162
739
R06AE07
ATC
cetirizine; oral
2.3
22.0
299
1812
M05BA04
ATC
alendronic acid; oral
3.6
20.7
75
231
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
20.6
152
699
J01MA12
ATC
levofloxacin; systemic
2.6
20.5
146
660
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
20.2
97
355
R01AD09
ATC
mometasone; nasal
2.2
20.2
313
1979
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
20.1
74
230
R03DC01
ATC
zafirlukast; oral
8.5
19.8
26
32
R01AD12
ATC
fluticasone furoate; nasal
2.3
19.5
220
1218
A02BC02
ATC
pantoprazole; systemic
2.3
18.9
434
3180
R03AC12
ATC
salmeterol; inhalant
4.3
18.7
51
128
3028
Kela drug reimbursment
Mepolizumab
195.9
18.6
19
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
18.3
174
892
J01MA14
ATC
moxifloxacin; systemic
3.1
18.1
82
290
R03BA01
ATC
beclometasone; inhalant
2.7
18.0
112
471
2883X
ICD-9 Finland
Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]
+∞
17.8
17
*
297, ,
Kela drug reimbursment
185.3
17.6
18
*
R03DX09
ATC
mepolizumab; parenteral
185.3
17.6
18
*
R05
ICD-10 Finland
Cough
2.4
17.6
152
746
R03AC13
ATC
formoterol; inhalant
3.9
17.5
53
144
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
17.5
350
2396
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.4
17.3
28
19
GD1AD
NOMESCO Finland
Thorax CT examination
3.7
17.2
58
170
R06AE09
ATC
levocetirizine; oral
2.6
17.1
111
476
J01AA02
ATC
doxycycline; systemic
2.4
16.9
477
3714
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
16.8
56
163
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
174.7
16.6
17
*
DPA30
NOMESCO Finland
Sphenotomy
15.9
16.3
26
17
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
16.3
78
284
L29.9
ICD-10 Finland
Pruritus, unspecified
5.5
16.2
32
61
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
15.7
48
131
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
15.2
79
301
XG410
NOMESCO Finland
Flow-volume spirometry
4.1
14.9
42
108
A02BC01
ATC
omeprazole; systemic
2.1
14.9
190
1084
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
58.2
14.9
17
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
14.8
242
1511
L04AX01
ATC
azathioprine; systemic
4.0
14.6
42
110
JN4BD
NOMESCO Finland
Extensive body CT
2.7
14.4
83
334
J33.9
ICD-10 Finland
Nasal polyp, unspecified
12.4
14.2
25
21
L04AX03
ATC
methotrexate; systemic
2.8
14.2
79
312
R03DA04
ATC
theophylline; systemic, rectal
3.6
14.0
47
137
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
24.5
13.9
19
8
UJF30
NOMESCO Finland
Ileoscopy through colon
2.7
13.8
78
310
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.1
13.8
59
201
R03BA02
ATC
budesonide; inhalant
2.2
13.7
131
665
WX002
NOMESCO Finland
Sedation and analgesia
2.2
13.7
138
716
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
13.7
134
687
E0000UV, ,
ATC
1.9
13.7
267
1761
R06.0
ICD-10 Finland
Dyspnoea
2.0
13.6
182
1053
R01AD05
ATC
budesonide; nasal
3.0
13.3
61
216
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
13.0
166
941
D07AD01
ATC
clobetasol; topical
2.3
12.6
114
564
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
13.6
12.5
21
16
L04AA06
ATC
mycophenolic acid; systemic
5.8
12.5
23
41
R03AC03
ATC
terbutaline; inhalant
2.4
12.4
97
451
C03CA01
ATC
furosemide; systemic
2.0
12.2
183
1094
J01FF01
ATC
clindamycin; systemic
2.0
12.2
179
1063
WW200
NOMESCO Finland
Immunization
5.0
12.0
26
54
J31.0
ICD-10 Finland
Chronic rhinitis
2.7
11.9
68
272
UJF32
NOMESCO Finland
Coloscopy
2.0
11.8
170
1002
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.9
11.7
56
203
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.2
11.7
47
154
J01FA09
ATC
clarithromycin; systemic
1.9
11.6
199
1241
N18.8
ICD-10 Finland
Other chronic renal failure
5.2
11.6
24
48
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
11.4
150
854
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
11.3
71
298
R06AX27
ATC
desloratadine; oral
1.9
11.2
183
1122
R06AX13
ATC
loratadine; oral
2.2
11.1
101
500
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
4.8
11.0
25
54
D07AC01
ATC
betamethasone; topical
1.8
11.0
225
1480
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
21.9
10.7
15
7
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.4
10.7
80
363
T78.4
ICD-10 Finland
Allergy, unspecified
3.5
10.7
37
110
395
Kela drug reimbursment
Dupilumab
61.1
10.7
12
*
J01FA06
ATC
roxithromycin; oral
1.8
10.4
245
1675
UDM02
NOMESCO Finland
Sinoscopy
4.4
10.4
26
61
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
10.4
220
1458
318
Kela drug reimbursment
Teriparatide
33.2
10.4
13
*
H05AA02
ATC
teriparatide; parenteral
33.2
10.4
13
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.9
10.3
30
79
J47
ICD-10 Finland
Bronchiectasis
5.0
10.3
22
45
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.3
110
579
R06AX22
ATC
ebastine; oral
2.1
10.2
112
595
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
10.2
125
692
M05BX04
ATC
denosumab; parenteral
3.2
10.1
40
130
J01DB01
ATC
cefalexin; oral
2.1
10.0
498
4233
R01AD58
ATC
fluticasone, combinations; nasal
1.9
9.8
152
910
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.0
9.8
45
160
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.3
9.7
25
60
D11AH05
ATC
dupilumab; topical
55.9
9.7
11
*
R03DX10
ATC
benralizumab; systemic
55.9
9.7
11
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.8
9.7
30
83
D07AC13
ATC
mometasone; topical
1.8
9.6
174
1094
ZXA10
NOMESCO Finland
Bilateral
2.0
9.6
122
683
R06.2
ICD-10 Finland
Wheezing
3.2
9.6
39
129
I42.3
ICD-10 Finland
Endomyocardial (eosinophilic) disease
+∞
9.4
9
*
B01AA03
ATC
warfarin; systemic
2.0
9.4
113
620
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
9.4
22
49
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.0
9.4
20
41
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
9.4
186
1202
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.9
9.2
27
72
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.4
9.1
66
295
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.3
9.1
71
328
A07AA02
ATC
nystatin; oral
2.9
9.0
42
150
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
9.0
65
290
R01AD01
ATC
beclometasone; nasal
2.0
9.0
101
541
B03XA02
ATC
darbepoetin alfa; parenteral
4.6
8.9
21
47
A46
ICD-10 Finland
Erysipelas
2.1
8.8
91
471
SPAT1254
SPAT
Administration of medicine
2.1
8.8
95
500
R02
ICPC
Shortness of breath/dyspnoea
2.1
8.8
85
429
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
8.7
136
814
3027
Kela drug reimbursment
Benralizumab
50.7
8.7
10
*
J01FA10
ATC
azithromycin; systemic
1.7
8.6
342
2653
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.9
8.6
42
154
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
16.6
8.6
13
8
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
8.5
74
358
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.6
8.5
51
209
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
8.4
105
582
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
8.4
59
260
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.7
8.4
26
72
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.3
255
1847
J01CA04
ATC
amoxicillin; systemic
1.9
8.2
485
4171
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.5
8.2
20
46
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
8.1
128
767
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
8.1
159
1019
R20.2
ICD-10 Finland
Paraesthesia of skin
2.6
8.0
49
202
A02BC05
ATC
esomeprazole; systemic
1.7
7.9
238
1708
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.5
7.9
27
80
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.4
7.9
28
85
UDC00
NOMESCO Finland
Ear microscopy
2.4
7.8
54
236
D07AB08
ATC
desonide; topical
2.1
7.8
75
377
L04AA01
ATC
[U] ciclosporin
9.6
7.8
15
16
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.1
7.7
21
53
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.8
7.6
18
27
Z3231
NOMESCO Finland
Registered nurse
1.7
7.6
165
1083
C07AB07
ATC
bisoprolol; oral
1.6
7.6
279
2101
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
7.3
7.5
17
24
R53
ICD-10 Finland
Malaise and fatigue
1.8
7.5
146
930
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
7.5
247
1808
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.5
7.5
18
41
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
7.4
95
532
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
7.3
27
84
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
7.3
168
1119
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.4
7.3
26
79
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.8
7.3
37
139
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
7.4
7.2
16
22
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.0
7.2
31
106
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
7.2
41
164
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
7.1
111
662
S97
ICPC
Chronic ulcer skin
2.5
7.1
46
196
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
7.0
72
372
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.8
7.0
21
57
D02AE01
ATC
carbamide; topical
2.5
7.0
44
185
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.9
279
2130
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.5
6.9
43
180
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
6.8
30
104
251, ,
Kela drug reimbursment
40.5
6.8
8
*
M81.4
ICD-10 Finland
Drug-induced osteoporosis
22.8
6.7
9
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.1
6.7
18
45
R01AD11
ATC
triamcinolone; nasal
2.2
6.6
54
255
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.2
6.6
17
41
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
6.6
61
303
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
10.2
6.6
12
12
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
7.0
6.5
15
22
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.5
247
1853
L50.9
ICD-10 Finland
Urticaria, unspecified
3.0
6.5
28
96
XG405
NOMESCO Finland
Education on PEF monitoring
6.3
6.5
16
26
SPAT1263
SPAT
Sampling
1.6
6.5
245
1836
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
6.5
203
1457
B44.8
ICD-10 Finland
Other forms of aspergillosis
70.6
6.4
7
*
B01AB10
ATC
tinzaparin; parenteral
2.1
6.4
62
313
UJF92
NOMESCO Finland
Capsular endoscopy
4.1
6.4
17
42
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.1
6.4
17
42
A03
ICPC
Fever
1.8
6.4
101
603
L28.1
ICD-10 Finland
Prurigo nodularis
8.3
6.4
13
16
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.4
175
1216
TQW80
NOMESCO Finland
Local dermatologic skincare
3.5
6.3
21
61
AA1AD
NOMESCO Finland
CT of head and brain
1.7
6.3
152
1020
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
11.2
6.3
11
10
E000001, ,
ATC
1.8
6.3
115
716
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
6.3
114
708
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.1
6.3
25
82
D02AX
ATC
Other emollients and protectives
3.1
6.3
25
82
L50.0
ICD-10 Finland
Allergic urticaria
3.6
6.2
20
57
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
6.2
62
317
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
6.2
95
562
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.8
6.2
31
116
JN4AD
NOMESCO Finland
Body CT examination
2.0
6.1
63
325
TK800
NOMESCO Finland
Hemodialysis
3.8
6.1
18
48
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
4.2
6.1
16
39
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.7
6.1
31
117
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
6.1
46
210
J02AC01
ATC
fluconazole; systemic
1.6
6.1
208
1519
127
Kela drug reimbursment
Transplant complication
5.3
6.0
17
33
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
259
296
14.72
225.50
2.8
1.2
618.14
241.45
u/ml
1.78
250
274
186
221
11.79
153.32
1.8
1.4
3.50
10.94
u/ml
—
5
5
154
176
11.46
129.37
2.1
1.6
296.67
220.00
titre
—
12
7
139
155
11.40
118.37
2.2
1.6
—
—
—
0
0
180
382
6.32
85.72
3.3
2.3
10.54
10.43
g/l
0.12
165
347
127
200
7.80
80.59
1.6
2.2
42.61
39.00
u/l
0.80
118
181
88
87
11.70
80.45
3.9
3.1
4.84
4.19
e9/l
1.26
88
87
103
129
9.45
79.19
1.7
2.2
11.78
12.26
mg/l
0.16
95
120
88
89
11.43
79.18
4.2
3.4
56.06
58.21
%
0.60
88
89
459
2277
5.44
73.98
14.3
5.9
7.13
2.85
%
27.36
447
2138
199
522
5.23
73.75
4.7
4.2
255.09
244.12
u/l
0.26
192
496
464
2357
5.40
71.53
14.4
6.1
25.24
27.79
%
6.43
451
2225
479
2508
5.67
70.66
15.2
6.2
0.55
0.19
e9/l
28.39
455
2223
150
318
5.97
70.52
1.8
1.6
1.08
1.43
g/l
1.40
138
295
57
34
18.43
69.45
1.9
1.1
5.90
0.55
u/ml
1.05
28
22
457
2331
5.14
69.03
13.5
5.9
54.87
57.26
%
3.85
444
2200
163
449
4.62
55.38
3.1
2.0
314.47
372.50
nmol/l
3.34
158
414
176
517
4.41
54.96
2.6
2.8
1.74
1.79
%
0.24
160
475
477
2800
4.55
52.50
16.2
9.1
4.48
4.14
e9/l
1.86
460
2473
137
383
4.35
44.95
2.5
2.6
63.80
69.53
e9/l
1.43
108
295
132
374
4.25
42.38
2.2
2.8
65.16
66.47
g/l
0.99
119
341
225
1010
2.97
34.22
1.9
1.4
2.20
2.46
g/l
1.49
171
618
37
36
10.89
33.65
1.3
1.1
—
—
—
0
0
37
36
10.89
33.65
1.3
1.1
—
—
—
0
0
170
661
3.20
33.16
3.5
2.5
22.31
23.33
%
0.44
146
569
218
1004
2.85
31.11
3.2
2.6
5.13
4.73
e6/l
0.15
198
904
405
2554
2.83
30.93
7.1
6.2
9.92
11.60
umol/l
4.09
397
2425
171
694
3.05
30.71
3.5
2.4
2.26
2.32
g/l
0.63
161
645
506
3616
3.67
30.61
8.2
4.1
14.48
11.98
mm/h
2.67
481
3318
135
484
3.31
29.85
4.9
3.3
—
—
—
0
0
379
2337
2.71
29.80
10.4
7.3
1.21
1.21
mmol/l
0.14
289
2001
331
1921
2.63
29.30
2.9
2.3
77.92
76.38
nmol/l
0.43
308
1718
357
2156
2.64
28.98
9.3
6.5
1.21
1.21
mmol/l
0.07
333
1963
63
137
5.02
27.76
2.5
4.2
44.26
100.84
mg/l
0.66
40
113
63
137
5.02
27.76
2.5
4.3
36.09
30.32
mg/l
0.43
40
114
69
162
4.69
27.75
1.7
2.3
—
—
—
0
0
510
3757
3.50
27.30
11.8
7.3
77.42
78.17
u/l
0.18
495
3524
46
76
6.48
27.12
2.6
3.9
1220.00
3477.86
u/ml
—
5
7
334
2005
2.52
26.67
6.3
4.9
33.59
35.69
g/l
7.70
306
1882
73
186
4.33
26.45
1.3
1.2
0.23
3.36
u/ml
—
7
8
173
763
2.79
26.16
3.5
2.4
12.13
13.14
umol/l
1.18
162
712
148
602
2.94
26.02
9.0
6.5
1.09
1.04
mmol/l
1.06
138
559
37
51
7.67
25.71
1.9
1.7
32.86
33.24
pg
0.18
37
51
109
374
3.34
25.63
5.0
3.5
1.22
1.23
mmol/l
0.38
95
329
28
5
58.62
24.23
1.1
1.0
—
—
—
0
0
171
778
2.68
24.09
2.1
1.9
—
—
—
0
0
168
758
2.69
24.06
4.4
3.8
0.80
0.81
mmol/l
0.50
156
717
50
107
5.01
22.38
1.4
1.4
—
—
—
0
0
258
1481
2.31
21.42
3.9
3.3
15.08
112.29
e6/l
1.46
219
1131
241
1345
2.33
21.37
3.7
3.2
0.15
0.50
e6/l
3.65
205
1005
348
2271
2.28
21.11
16.3
14.2
1.26
1.25
inr
0.02
162
653
300
1842
2.27
21.10
5.3
3.6
40.80
57.08
ng/l
0.36
215
1289
288
1741
2.27
21.01
4.0
3.3
—
—
—
0
0
65
182
3.89
20.62
2.4
2.2
7.34
7.42
g/l
0.12
56
168
65
182
3.89
20.62
2.4
2.2
—
—
—
0
0
65
182
3.89
20.62
2.4
2.2
3.71
3.60
g/l
0.22
55
168
47
103
4.87
20.44
1.5
1.5
—
—
—
0
0
61
169
3.91
19.63
2.3
2.3
3.13
3.05
g/l
0.23
52
155
265
1586
2.21
19.39
2.8
3.3
2.32
2.35
mmol/l
3.46
241
1400
26
33
8.19
19.29
1.7
1.9
0.21
0.16
e9/l
0.59
19
28
60
168
3.86
19.01
2.4
2.2
10.24
10.36
g/l
0.06
50
153
26
34
7.95
18.82
1.7
1.9
363.74
441.04
e6/l
0.46
19
28
43
94
4.85
18.74
2.8
2.5
16.34
15.94
%
0.18
24
51
57
156
3.94
18.64
2.0
3.0
—
—
—
0
0
31
51
6.36
18.29
1.2
1.1
—
—
—
0
0
42
92
4.84
18.26
1.7
1.7
—
—
—
0
0
41
88
4.93
18.25
1.6
1.4
—
—
—
0
0
25
33
7.86
17.95
1.8
1.4
—
—
—
0
0
235
1374
2.17
17.90
4.0
3.1
2127.93
1234.19
ng/l
0.72
211
1195
68
216
3.43
17.85
1.6
2.1
1.58
1.52
g/l
0.22
56
187
32
56
5.98
17.76
1.8
1.8
—
—
—
0
0
45
107
4.47
17.71
1.4
1.4
—
—
—
0
0
53
143
3.97
17.67
2.5
2.4
0.00
0.04
g/l
0.50
45
136
44
103
4.53
17.65
1.4
1.5
237.43
254.98
u/ml
0.14
30
58
398
2856
2.19
17.65
6.7
4.9
6.70
6.70
mmol/l
0.01
380
2661
123
548
2.57
17.55
1.9
1.8
—
—
—
0
0
40
88
4.80
17.30
1.7
1.4
—
—
—
0
0
123
552
2.55
17.26
2.0
1.9
—
—
—
0
0
130
599
2.50
17.25
2.4
2.4
147.56
115.75
ug/g
0.32
112
476
100
405
2.77
17.23
11.1
8.6
11.39
9.81
mmol/l
1.28
94
389
55
157
3.76
16.93
2.5
2.5
0.64
1.03
g/l
0.39
46
143
200
1120
2.18
16.79
1.5
1.3
0.61
1.74
u/ml
1.78
56
289
36
75
5.04
16.58
1.4
1.1
0.74
2.61
u/ml
1.30
23
41
33
64
5.40
16.45
1.3
1.1
2.13
2.26
u/ml
0.02
18
31
107
461
2.61
16.27
2.0
2.4
0.21
0.21
g/l
0.18
100
432
48
128
3.99
16.25
1.7
1.6
—
—
—
0
0
41
97
4.47
16.23
1.6
1.5
117.00
99.13
u/ml
—
8
15
238
1444
2.08
16.07
3.2
2.1
142.76
312.64
u/l
1.68
222
1352
24
14
17.81
15.73
1.3
1.1
—
—
—
0
0
210
1225
2.10
15.67
3.3
2.9
1534.81
6958.18
umol/l
2.30
194
1072
48
132
3.87
15.57
2.6
2.4
0.00
0.00
g/l
-0.00
40
125
53
158
3.58
15.30
1.6
1.5
0.00
0.12
iu/ml
—
8
32
47
130
3.84
15.12
2.6
2.4
0.00
0.00
g/l
-0.00
40
124
204
1194
2.08
14.96
3.0
2.1
2.90
3.02
mg/l
0.35
179
1031
32
66
5.07
14.90
1.6
1.5
—
—
—
0
0
217
1301
2.05
14.89
5.0
3.9
0.00
0.01
estimate
0.88
118
438
50
149
3.57
14.43
2.5
2.3
36.16
37.67
g/l
0.93
40
135
45
125
3.81
14.39
1.9
1.6
—
—
—
0
0
310
2124
1.96
14.38
4.4
2.7
150.26
128.98
ug/l
0.66
287
1955
156
838
2.17
14.22
1.3
1.3
38.05
34.40
iu/ml
0.14
52
282
28
54
5.39
14.03
1.2
1.0
4.54
3.07
u/ml
0.19
16
22
249
1614
1.93
13.33
3.8
3.3
41.91
32.58
u/l
0.45
237
1534
240
1539
1.94
13.25
3.0
2.5
55.43
59.98
u/l
0.61
225
1428
21
14
15.50
13.18
1.3
1.1
—
—
—
0
0
45
133
3.58
13.15
1.5
1.6
—
—
—
0
0
32
74
4.51
13.02
1.8
1.6
—
—
—
0
0
24
43
5.77
12.99
1.0
1.0
—
—
—
0
0
45
136
3.50
12.71
1.2
1.3
6.91
2.66
u/ml
—
7
16
45
137
3.47
12.57
1.2
1.3
8.69
12.73
u/ml
—
8
23
35
90
4.07
12.44
1.6
1.5
—
—
—
0
0
24
26
9.57
12.09
1.6
2.3
—
—
—
0
0
195
1196
1.94
12.07
6.3
4.2
87.03
90.41
%
0.99
187
1169
335
2441
1.85
12.05
4.4
3.6
0.00
0.01
estimate
0.50
114
426
20
15
13.75
12.01
5.3
5.4
—
—
—
0
0
331
2410
1.84
11.86
5.5
4.9
0.00
0.00
estimate
0.50
124
450
79
342
2.51
11.75
2.1
1.5
—
—
—
0
0
329
2411
1.82
11.35
4.5
3.6
0.00
0.00
estimate
0.50
126
476
456
3706
1.99
11.26
4.6
3.8
14.97
14.75
pmol/l
1.08
413
3345
557
4911
3.10
11.25
28.7
13.8
20.46
23.70
mg/l
1.96
501
3858
21
22
9.85
10.83
1.7
1.5
—
—
—
0
0
22
26
8.74
10.62
2.1
2.0
1029.68
835.46
u/ml
0.42
22
26
21
23
9.42
10.58
1.7
1.5
—
—
—
0
0
24
53
4.68
10.33
1.0
1.0
—
—
—
0
0
138
793
1.96
10.12
1.3
1.3
13.05
12.74
u/ml
0.02
45
314
29
76
3.96
10.06
1.6
1.4
—
—
—
0
0
162
988
1.88
9.91
1.7
1.7
115079772.80
6090564.96
pmol/l
0.46
126
821
27
68
4.11
9.87
1.2
1.3
—
—
—
0
0
19
20
9.77
9.82
1.1
1.1
—
—
—
0
0
44
156
2.97
9.60
1.5
1.4
—
—
—
0
0
150
909
1.87
9.29
6.0
3.7
338.73
356.31
ng/l
0.04
122
697
21
29
7.47
9.29
1.7
1.4
—
—
—
0
0
26
67
4.01
9.23
1.6
1.5
—
—
—
0
0
172
1091
1.81
9.18
2.7
1.9
1.35
1.24
mg/l
0.17
136
833
499
4293
2.01
8.98
33.0
16.6
14.69
14.90
%
0.42
494
4232
128
744
1.92
8.98
5.9
2.5
30.87
29.88
s
0.59
128
722
15
12
12.79
8.90
1.0
1.8
—
—
—
0
0
35
114
3.20
8.81
1.1
1.2
52.20
31.10
u/ml
—
5
11
259
1863
1.69
8.77
4.8
3.8
—
—
—
0
0
21
32
6.76
8.73
2.1
1.5
31.00
28.60
u/ml
—
5
5
103
561
2.01
8.71
3.7
3.3
7.34
8.34
umol/l
0.23
82
488
396
3203
1.71
8.45
5.3
4.4
95.25
3095.96
e6/l
—
8
52
19
41
4.75
8.40
1.6
1.4
30.55
30.41
%
0.00
12
29
24
63
3.93
8.32
1.4
1.1
—
—
—
0
0
400
3260
1.69
8.13
3.7
3.2
60.13
47.11
u/l
1.46
372
3053
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
154
2.79
8.07
14.5
3.6
0.38
0.34
u/ml
0.25
29
82
218
1524
1.68
8.06
3.5
3.2
7.14
7.68
mmol/l
1.07
180
1280
34
117
3.02
7.83
1.4
1.9
—
—
—
0
0
19
46
4.23
7.32
1.2
1.0
0.08
1.03
u/ml
—
10
13
7
0
+∞
7.30
1.0
0.0
—
—
—
0
0
17
26
6.70
7.15
1.5
1.2
—
—
—
0
0
135
852
1.76
7.13
1.9
1.7
1072.53
1193.16
nmol/l
0.90
103
654
37
141
2.73
7.11
1.6
1.4
274.30
294.81
ug/g
0.21
20
84
32
113
2.94
7.06
1.3
1.2
—
—
—
0
0
84
459
1.97
6.99
5.6
4.5
1.33
2.03
mmol/l
0.76
69
376
256
1916
1.59
6.94
2.1
1.9
98.74
94.26
pmol/l
0.58
139
1003
20
53
3.87
6.86
1.6
1.6
53.71
64.44
%
0.52
14
41
36
138
2.71
6.84
1.3
1.1
—
—
—
0
0
550
5019
2.27
6.74
28.8
16.1
3.97
3.98
mmol/l
0.33
543
4873
58
282
2.17
6.59
2.5
3.3
4.58
4.57
pmol/l
0.02
47
251
83
461
1.93
6.58
5.6
4.5
5.74
5.75
kpa
0.06
75
447
17
30
5.80
6.49
1.0
1.1
—
—
—
0
0
17
42
4.14
6.39
1.2
1.1
—
—
—
0
0
17
42
4.14
6.39
1.2
1.1
—
—
—
0
0
504
4490
1.80
6.25
5.6
4.6
1.89
2.18
mu/l
0.55
473
4089
17
43
4.04
6.20
1.2
1.1
—
—
—
0
0
17
43
4.04
6.20
1.2
1.1
—
—
—
0
0
17
43
4.04
6.20
1.2
1.1
—
—
—
0
0
512
4587
1.83
6.17
24.5
12.6
79.05
82.07
ml/min/173m2
2.09
464
3771
12
14
8.72
6.08
2.0
1.3
—
—
—
0
0
131
857
1.68
5.99
2.8
2.9
2.45
2.45
mmol/l
0.06
112
761
159
1105
1.60
5.69
1.8
1.5
17.83
20.94
nmol/l
1.94
141
930
200
1469
1.54
5.61
4.4
3.9
16.29
11.27
mg/mmol
0.44
131
938
62
330
1.98
5.56
6.4
4.7
1.80
1.65
mmol/l
0.16
47
250
14
24
5.95
5.56
1.3
1.0
—
—
—
0
0
68
388
1.85
4.96
4.0
3.9
4.57
4.66
kpa
0.13
61
376
17
53
3.27
4.64
1.2
1.1
—
—
—
0
0
27
111
2.50
4.53
1.2
1.8
484.59
429.52
mg/l
0.44
27
103
22
82
2.75
4.46
1.3
1.3
2.14
5.11
u/ml
—
7
27
16
50
3.26
4.36
1.2
1.1
—
—
—
0
0
14
33
4.32
4.34
1.1
1.2
—
—
—
0
0
15
38
4.02
4.32
1.5
1.4
—
—
—
0
0
24
96
2.56
4.26
1.5
1.7
—
—
—
0
0
24
96
2.56
4.26
1.5
1.7
—
—
—
0
0
169
1263
1.47
4.17
1.8
1.7
1.50
1.39
mmol/l
0.74
126
1065
7
7
10.10
4.02
1.7
1.6
—
—
—
0
0
554
5213
1.91
3.99
17.6
10.2
26.97
26.54
u/l
0.16
547
5018
14
43
3.31
3.93
1.1
1.1
—
—
—
0
0
20
77
2.65
3.84
1.6
1.3
—
—
—
0
0
60
357
1.76
3.84
6.1
4.3
113.43
80.54
ng/l
1.84
54
320
10
19
5.33
3.84
2.4
3.8
213.10
214.16
u/l
—
10
19
12
28
4.35
3.83
1.3
1.1
—
—
—
0
0
12
28
4.35
3.83
1.3
1.1
—
—
—
0
0
20
78
2.62
3.75
1.6
1.3
—
—
—
0
0
20
78
2.62
3.75
1.6
1.3
—
—
—
0
0
119
848
1.50
3.68
3.1
2.8
0.63
0.95
e6/l
1.38
72
490
21
85
2.52
3.67
1.3
1.3
4.60
6.97
u/ml
—
10
38
20
79
2.58
3.66
1.6
1.3
—
—
—
0
0
20
79
2.58
3.66
1.6
1.3
—
—
—
0
0
20
79
2.58
3.66
1.6
1.3
—
—
—
0
0
71
449
1.66
3.65
2.7
2.4
30.54
33.48
u/l
0.34
63
381
16
56
2.91
3.65
1.2
1.2
—
—
—
0
0
12
30
4.06
3.61
1.3
1.1
—
—
—
0
0
12
30
4.06
3.61
1.3
1.1
—
—
—
0
0
82
545
1.59
3.46
10.1
8.7
1.10
1.30
mmol/l
0.17
59
436
16
58
2.81
3.44
1.4
1.8
—
—
—
0
0
27
128
2.16
3.35
1.6
1.3
—
—
—
0
0
27
128
2.16
3.35
1.3
1.4
—
—
—
0
0
13
38
3.47
3.33
1.3
1.2
—
—
—
0
0
10
23
4.40
3.32
1.4
1.7
—
—
—
0
0
11
28
3.98
3.30
1.5
1.6
—
—
—
0
0
11
28
3.98
3.30
1.5
1.6
—
—
—
0
0
19
79
2.45
3.16
1.3
1.1
—
—
—
0
0
32
166
1.98
3.15
2.5
2.4
3706.19
2700.60
u/l
—
10
69
484
4464
1.45
3.13
6.6
5.7
40.76
39.74
mmol/mol
1.21
446
4130
8
16
5.05
3.06
2.1
2.4
39038.13
39343.75
ug/l
—
8
16
13
45
2.93
3.04
1.5
1.3
9320.37
36760.75
e6/l
—
8
24
20
87
2.34
3.04
1.1
1.0
—
—
—
0
0
80
546
1.54
3.02
10.5
8.7
5.02
5.11
kpa
0.41
74
526
80
546
1.54
3.02
10.4
8.7
11.46
12.09
kpa
0.77
74
528
11
31
3.60
3.00
1.2
1.1
—
—
—
0
0
359
3169
1.33
2.95
3.5
3.1
—
—
—
0
0
15
58
2.63
2.89
10.6
6.8
13.40
10.80
mg/l
1.39
15
53
9
22
4.14
2.89
1.4
1.7
—
—
—
0
0
9
22
4.14
2.89
1.4
1.7
—
—
—
0
0
9
22
4.14
2.89
1.1
1.0
—
—
—
0
0
14
53
2.68
2.81
1.4
1.6
—
—
—
0
0
14
53
2.68
2.81
1.4
1.6
—
—
—
0
0
14
53
2.68
2.81
1.4
1.6
—
—
—
0
0
34
189
1.85
2.76
2.3
1.8
—
—
—
0
0
11
34
3.28
2.74
1.4
2.4
—
—
—
0
0
11
34
3.28
2.74
1.4
2.4
—
—
—
0
0
47
289
1.68
2.73
1.9
1.7
—
—
—
0
0
14
54
2.63
2.72
1.2
1.4
—
—
titre
—
0
0
47
291
1.67
2.66
1.6
1.4
—
—
—
0
0
16
67
2.43
2.65
1.5
1.7
—
—
—
0
0
107
795
1.42
2.65
3.4
3.0
1.76
2.02
e6/l
0.16
60
440
271
2323
1.31
2.64
3.4
2.5
—
—
—
0
0
14
55
2.58
2.63
4.4
3.7
—
—
—
0
0
23
119
1.97
2.33
1.4
1.4
—
—
—
0
0
11
40
2.78
2.28
1.5
1.5
84.91
76.90
umol/l
0.61
11
40
52
345
1.56
2.26
1.3
1.2
97.99
165.22
iu/ml
0.71
20
132
57
387
1.52
2.24
3.4
2.7
51.93
67.02
ml/min/173m2
2.66
29
158
14
60
2.37
2.23
1.2
1.1
—
—
—
0
0
59
408
1.50
2.13
2.6
2.4
20.19
6.87
ug/l
0.51
53
364
566
5474
1.70
2.09
40.8
20.3
271.03
248.49
e9/l
12.00
560
5340
566
5474
1.70
2.09
41.5
20.4
39.85
40.28
%
1.06
541
5109
566
5478
1.68
2.02
40.7
20.3
4.42
4.51
e12/l
4.01
560
5333
7
21
3.36
1.97
1.1
1.3
—
—
—
0
0
8
27
2.99
1.94
1.5
1.3
1.93
1.82
mmol/l
—
8
27
6
16
3.78
1.94
1.3
1.1
—
—
—
0
0
7
22
3.21
1.88
1.4
1.3
—
—
—
0
0
29
175
1.69
1.86
1.9
1.7
—
—
—
0
0
6
17
3.55
1.84
1.2
1.0
—
—
—
0
0
5
12
4.19
1.82
1.4
1.3
—
—
—
0
0
21
116
1.84
1.80
1.5
1.6
20674.27
17017.96
e6/l
0.13
15
90
8
29
2.78
1.79
1.1
1.1
327.50
182.68
iu/ml
—
8
29
11
47
2.37
1.78
1.5
1.7
—
—
—
0
0
513
4894
1.35
1.76
5.4
4.9
2.68
2.75
mmol/l
0.99
475
4495
78
594
1.36
1.70
12.7
7.0
103.81
104.15
mmol/l
0.23
78
594
12
56
2.17
1.62
2.8
2.3
—
—
—
0
0
21
121
1.76
1.60
1.3
1.1
—
—
—
0
0
110
889
1.29
1.59
1.6
1.5
—
—
—
0
0
6
20
3.02
1.58
1.7
1.4
—
—
—
0
0
495
4719
1.29
1.54
5.2
4.5
5.99
5.95
mmol/l
0.18
453
4289
504
4818
1.30
1.52
5.0
4.4
4.58
4.64
mmol/l
0.68
468
4451
5
15
3.35
1.52
1.2
1.0
2388.00
1405.27
miu/ml
—
5
15
11
51
2.18
1.51
2.4
2.6
3.36
6.66
nmol/l
0.50
11
51
78
608
1.33
1.47
1.6
1.7
1.63
1.50
%
0.92
69
539
25
158
1.61
1.39
1.6
1.4
461.05
280.06
mu/l
1.06
20
144
5
17
2.96
1.36
1.0
1.6
—
—
—
0
0
30
437
0.67
1.34
2.0
1.7
—
—
—
0
0
34
235
1.47
1.30
1.5
1.9
—
—
—
0
0
13
69
1.90
1.29
1.5
1.7
—
—
—
0
0
13
69
1.90
1.29
1.5
1.7
—
—
—
0
0
10
48
2.10
1.28
1.4
1.4
—
—
—
0
0
24
154
1.58
1.28
1.4
1.1
—
—
—
0
0
46
614
0.73
1.27
5.5
4.5
30.88
31.69
%
0.21
34
410
24
155
1.57
1.25
1.4
1.1
—
—
—
0
0
10
49
2.06
1.22
2.4
2.2
—
—
—
0
0
5
19
2.64
1.22
1.0
1.2
—
—
—
0
0
20
125
1.62
1.19
2.7
2.3
308.18
113.00
ug/min
0.38
13
68
13
73
1.80
1.11
1.4
1.1
—
—
—
0
0
14
81
1.75
1.09
1.6
1.5
—
—
—
0
0
8
41
1.96
1.09
1.6
1.5
—
—
—
0
0
28
196
1.45
1.04
1.6
1.4
26.91
25.31
iu/l
0.07
19
167
5
22
2.28
1.03
1.0
1.1
0.32
0.29
g/l
—
5
17
16
99
1.63
1.01
1.6
1.5
—
—
—
0
0
5
23
2.18
0.98
1.2
1.4
1.52
1.57
g/l
—
5
23
47
596
0.77
0.94
6.7
7.0
—
—
—
0
0
60
483
1.27
0.94
3.4
4.3
108.21
30.56
ug/l
0.37
49
401
36
270
1.35
0.93
4.1
2.7
0.25
0.17
e6/l
0.18
36
263
495
4787
1.20
0.93
5.0
4.3
1.42
1.45
mmol/l
0.90
458
4395
6
28
2.15
0.91
1.2
1.1
—
—
—
0
0
6
30
2.01
0.87
1.3
1.5
—
—
—
0
0
6
30
2.01
0.87
1.2
1.6
0.81
1.08
g/l
—
6
30
17
239
0.70
0.70
1.5
1.5
—
—
—
0
0
11
69
1.61
0.68
1.5
2.5
5.32
4.97
umol/l
—
5
51
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
1.6
1.3
—
—
—
0
0
34
267
1.29
0.68
1.0
1.1
—
—
—
0
0
38
304
1.27
0.67
1.6
1.9
—
—
—
0
0
476
4630
1.14
0.62
4.5
3.9
1.40
1.28
mmol/l
2.63
437
4241
5
30
1.67
0.61
8.6
3.4
—
—
—
0
0
33
264
1.26
0.59
1.4
1.3
—
—
—
0
0
63
541
1.18
0.59
2.2
1.9
—
—
—
0
0
6
35
1.72
0.58
19.0
15.8
1821.83
1606.31
nmol/l
—
6
35
128
1162
1.13
0.57
4.2
2.3
—
—
—
0
0
67
591
1.15
0.47
2.3
2.0
—
—
—
0
0
5
31
1.62
0.43
1.4
1.4
—
—
—
0
0
18
141
1.29
0.40
1.7
1.4
—
—
—
0
0
5
34
1.47
0.40
1.4
1.3
—
—
—
0
0
13
97
1.35
0.39
1.8
1.7
—
—
—
0
0
19
235
0.80
0.37
1.7
2.7
18.63
39.96
u/ml
1.22
19
224
15
184
0.81
0.29
1.5
1.9
—
—
—
0
0
15
121
1.25
0.28
1.2
1.3
—
—
—
0
0
175
1677
1.06
0.25
5.3
5.0
9.10
2.65
ug/l
0.46
162
1511
43
388
1.12
0.25
2.3
2.2
11.76
12.92
nmol/l
0.43
36
348
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.5
—
1.28
—
0
10
6
52
1.16
0.19
2.3
1.2
2.00
3.30
ug/l
—
6
47
15
128
1.18
0.18
1.8
1.8
—
—
—
0
0
12
135
0.89
0.10
1.6
1.4
—
—
—
0
0
77
744
1.04
0.09
1.5
1.4
—
—
—
0
0
101
983
1.03
0.09
2.8
3.0
0.80
0.75
ug/l
0.17
70
665
12
107
1.12
0.08
1.9
1.6
—
—
—
0
0
13
117
1.11
0.08
2.2
1.7
12.50
7.35
iu/l
—
6
34
7
68
1.03
0.08
1.6
1.5
—
—
—
0
0
106
1077
0.98
0.04
4.8
3.8
1.02
1.02
kg/l
—
10
147
19
199
0.95
0.03
2.6
3.2
68.21
1545.65
u/ml
1.00
14
170
12
112
1.07
0.03
2.8
4.0
24.60
27.06
mg/l
—
5
68
22
228
0.96
0.02
4.8
3.7
50.60
51.01
%
0.03
22
223
11
105
1.05
0.00
2.2
1.9
183.45
237.98
pmol/l
0.84
11
97
6
62
0.97
0.00
1.3
1.2
—
—
—
0
0
9
92
0.98
0.00
2.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
135
1350
1.00
-0.00
4.1
4.4
22.24
21.27
%
0.35
69
655
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
11.60
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.80
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
60.57
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: D3_EOSINOPHILIA – Eosinophilia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).